GH Research PLC (GHRS)
9.59
-0.03
(-0.31%)
USD |
NASDAQ |
Nov 22, 14:53
GH Research Shareholders Equity (Quarterly): 189.37M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 189.37M |
| June 30, 2024 | 198.68M |
| March 31, 2024 | 209.75M |
| December 31, 2023 | 218.97M |
| September 30, 2023 | 225.77M |
| June 30, 2023 | 232.98M |
| March 31, 2023 | 241.83M |
| December 31, 2022 | 249.82M |
| Date | Value |
|---|---|
| September 30, 2022 | 256.74M |
| June 30, 2022 | 263.22M |
| March 31, 2022 | 269.48M |
| December 31, 2021 | 277.18M |
| September 30, 2021 | 283.60M |
| June 30, 2021 | 288.23M |
| March 31, 2021 | 4.315M |
| December 31, 2020 | 5.666M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
4.315M
Minimum
Mar 2021
288.23M
Maximum
Jun 2021
213.47M
Average
237.41M
Median
Shareholders Equity (Quarterly) Benchmarks
| Amarin Corp PLC | 531.38M |
| Jazz Pharmaceuticals PLC | 4.171B |
| Prothena Corp PLC | 534.36M |
| Iterum Therapeutics PLC | -6.15M |
| Mural Oncology PLC | 174.14M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 199.61M |
| Total Liabilities (Quarterly) | 10.24M |